Analyst Ratings for Clearside Biomedical (CLSD)
CLSD Rating Summary
CLSD Price Target Summary
- Highest: $3.00 (Needham)
- Lowest: $2.00 (Stifel)
- Average: $2.50
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$2.50 (+509.8%)
* Over Last 12-Mos
Rating Score: 3.1 / 10
Percentile Rank: 27%
Rating Score: 3.1 / 10
Percentile Rank: 27%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/18/2025 | H.C. Wainwright | Yi Chen | Downgrade | Neutral (Buy) |
N/A (N/A) |
0.60 (0.41) |
-31.67% | Details |
| 7/18/2025 | Chardan | Daniil Gataulin | Downgrade | Neutral (Buy) |
N/A (N/A) |
0.84 (0.41) |
-51.19% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
